Signature Genomic Laboratories Releases New Microarray for Prenatal Diagnosis
Posted on: Thursday, 6 November 2008, 11:17 CST
Signature Genomic Laboratories, a provider of microarray-based cytogenetic diagnostics, has launched a new enhanced microarray for the prenatal detection of chromosome abnormalities that result in missing or extra pieces of DNA.
The first tier of Signature's prenatal service, the enhanced PrenatalChip targets over 100 discrete chromosomal regions, the gain or loss of which results in a genetic disorder, while minimizing coverage of regions of unknown clinical significance.
Signature's whole-genome microarray, the SignatureChipWG, can be ordered if more coverage is required - especially in cases with abnormal findings by ultrasound, the company said.
Justine Coppinger, certified genetic counselor at Signature Genomic Laboratories, said: "Pregnancy can be a time of great anxiety, particularly if a genetic disorder is suspected. We approach prenatal diagnosis responsibly, balancing timely, comprehensive diagnoses with the desire to minimize anxiety over unclear results. We encourage physicians to discuss the most appropriate test for their patients with our certified genetic counselors."
Source: Datamonitor
Related Articles
- Defining Alzheimer's Genetic Signature
- ProGenTech Targets Clinical Diagnostics and Applied Sciences Markets With Human Genetic Signatures Deal
- Microchip to Aid Lung Cancer Treatments
- Genetic Signatures in Lebanon Traced Back to the Crusades
- Genetic Signature Predicts Recurrence of Breast, Prostate and Other Cancers, Stanford Researchers Find
- US Scientists Design Chip for Flu Identification
- Tracking Busy Genes to Get at Cancer
- TGen and Northern Arizona University Awarded a Multi-Million Dollar Grant to Identify Genetic Signatures of Pathogens
- Genetic Changes May Explain Cognitive Decline
- Genetic Changes May Explain Brain Decline
 |
 |
User Comments (0)
RSS Feeds